English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe scientists come from 21 US institutions and will join a community of Investigators who are tackling some of the most challenging problems in biomedical research.
Tag: Biomedical Research
Southwest National Primate Research Center and Texas Biomed receive continued full accreditation from lab animal care association
AAALAC, the international organization setting the gold standard for research animal care and use, has continued full accreditation status for SNPRC and Texas Biomed, citing dedicated staff and “extremely well cared for animals.”
Major NIH award to Wayne State to offer state-of-the-art proteomic research capabilities
Wayne State University has been awarded a $1.29 million high instrumentation grant from the National Institutes of Health to purchase a state-of-the-art mass spectrometer for identification and quantitation of proteins in biomedical research samples.
FIRST RESEARCH GRANTS AWARDED IN UTEP-TTUHSC EL PASO PARTNERSHIP
A partnership between The University of Texas at El Paso (UTEP) and Texas Tech Health Sciences Center El Paso (TTUHSC El Paso) designed to expand health research in the Paso del Norte region has identified studies which could have significant impact on the well-being of the community. The two institutions announced the first set of projects to receive funding from their Joint Seed Grant Program.
No Cancer Left Behind
A $15 million gift to Harvard Medical School from the Bertarelli Foundation is boosting efforts to understand and combat rare cancers. Nine teams across the school and its affiliated hospitals describe their efforts to illuminate understudied malignancies.
Through a $500 Million Partnership with the State of Ohio, JobsOhio and Ohio Development Services Agency, Cleveland Clinic Forms Global Center for Pathogen Research & Human Health
CLEVELAND: As part of the new Cleveland Innovation District announced today by State of Ohio Governor Mike DeWine, Lieutenant Governor Jon Husted, JobsOhio and Ohio Development Services Agency, Cleveland Clinic will significantly expand its global commitment to infectious disease research and translational programs to form the Global Center for Pathogen Research & Human Health.
The new Center will position Ohio as an international leader for research into emerging pathogens and virus-related diseases and will serve as a significant economic catalyst in Northeast Ohio. Funding comes through a $500 million investment from the State of Ohio, JobsOhio and Cleveland Clinic.
$11M NIH Grant Will Fund Biomedical Research at University of Delaware
the National Institutes of Health has renewed a Center of Biomedical Research Excellence (COBRE) grant at the University of Delaware. The COBRE research team is focused on discovery of new molecules that can be used to study and treat diseases such as breast cancer, renal cancer, Crohn’s disease, tuberculosis and Legionnaires disease.
Endocrine Society urges Congress to increase funding for NIH
The Endocrine Society—the world’s largest professional organization for endocrine scientists and physicians—is calling on Congress to pass the House Labor-HHS spending bill to ensure health agencies are funded before the start of Fiscal Year 2021 and to avoid the tumult and disruption of a continuing resolution and potential government shutdowns.
Soup to Nuts
The COVID-19 pandemic demands action on many fronts, from prevention to testing to treatment. Not content to focus its research efforts on just one, the laboratory of George Church in the Blavatnik Institute at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University is tackling the problem from seven different angles.
UTEP Researchers Develop Nanohybrid Vehicle to Optimally Deliver Drugs Into the Human Body
The researchers discovered that encapsulating ellagic acid in chitosan, a sugar, reduces its inherent cytotoxicity while enhancing its anti-oxidant properties. The chitosan shell, which makes up the hard outer skeleton of shellfish, also permits EA delivery via a rapid burst phase and a relatively slow phase.
The director of NIH visits UAB as COVID-19 appears
Francis Collins, M.D., Ph.D., director of the NIH, flew to Birmingham on Thursday, March 5, to start a long-anticipated visit to UAB. Collins soon learned he had a problem back home. Maryland public health officials were reporting the first two cases of COVID-19 in the county where the NIH sits.
Mayo Clinic researchers clarify how cells defend themselves from viruses
A protein known to help cells defend against infection also regulates the form and function of mitochondria, according to a new paper in Nature Communications.
International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands
Wistar and Leiden University Medical Center (LUMC) formalized a memorandum of understanding between the two institutions to explore a postdoctoral training exchange program in immunology, cancer research and vaccine biology. The Wistar-Schoemaker International Postdoctoral Fellowship would bring recent Ph.D. graduates trained at LUMC to Wistar to advance their research education under the mentorship of cutting-edge biomedical research leaders.
Southwest National Primate Research Center Welcomes New Veterinarian
Anna Goodroe, D.V.M., DACLAM, is the newest veterinarian to join the staff at the Southwest National Primate Research Center on the Texas Biomedical Research Institute campus. As an Assistant Veterinarian, she is part of the Veterinary Resources and Research Support team.
CNS Gift to the CNS Foundation Doubles Innovative Clinical Research Initiative, Creating Annual NINDS/CNSF K12 Scholar Awards
The Congress of Neurological Surgeons Foundation (CNS Foundation) announced a second K12 award will be funded by a generous gift from the Congress of Neurological Surgeons (CNS). The award is made possible through a collaboration with the Foundation of the National Institutes of Health (FNIH) and the National Institutes of Health (NIH).
Texas Biomed continues testing Ebola therapies and vaccines showing promise in outbreak areas
In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more than 2,100 lives in Africa. The findings resulted in the discontinuation of two of the drugs in the trial. Future patients will be randomly assigned to receive either REGN-EB3 (Regeneron) or mAb114 (Ridgeback Biotherapeutics) in an extension phase of the study. Texas Biomedical Research Institute scientists in the Institute’s Biosafety Level 4 contract research program conducted preclinical testing of several of the compounds in the trial, working with Regeneron and the Biomedical Advanced Research and Development Authority (BARDA).